Cutaneous drug reaction case reports: from the world literature.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000069287:Capecitabine; D002219:Carbamates / Q000009:adverse effects; D002443:Ceftriaxone / Q000009:adverse effects; D003000:Clonidine / Q000009:adverse effects / Q000031:analogs & derivatives*; D003841:Deoxycytidine / Q000009:adverse effects / Q000031:analogs & derivatives*; D003937:Diagnosis, Differential; D003875:Drug Eruptions / Q000175:diagnosis* / Q000209:etiology* / Q000473:pathology; D004975:Ethacridine / Q000009:adverse effects; D005260:Female; D005472:Fluorouracil / Q000031:analogs & derivatives; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D007190:Indapamide / Q000009:adverse effects; D015474:Isotretinoin / Q000009:adverse effects; D007555:Isoxazoles / Q000009:adverse effects; D000077339:Leflunomide; D008297:Male; D008875:Middle Aged; D019888:Nelfinavir / Q000009:adverse effects; D048448:Phenylcarbamates; D000068836:Rivastigmine; D012459:Salicylates / Q000009:adverse effects; D012720:Severity of Illness Index; D013449:Sulfonamides / Q000009:adverse effects; D013876:Thiophenes / Q000009:adverse effects
D002219:Carbamates; D007166:Immunosuppressive Agents; D007555:Isoxazoles; D048448:Phenylcarbamates; D012459:Salicylates; D013449:Sulfonamides; D013876:Thiophenes; D003841:Deoxycytidine; D000069287:Capecitabine; D002443:Ceftriaxone; C016986:apraclonidine; C062765:dorzolamide; D015474:Isotretinoin; D007190:Indapamide; D000077339:Leflunomide; D019888:Nelfinavir; D003000:Clonidine; D000068836:Rivastigmine; D005472:Fluorouracil; C014182:salicylsalicylic acid; D004975:Ethacridine